DIA/FDA Biostatistics Industry and Regulator Forum

Featured

Want to learn more about DIA/FDA Biostatistics Industry and Regulator Forum? You've come to the right site!

Karen Lynn Price, PhD Senior Research Fellow, Statistical Innovation Center/Design Hub
Eli Lilly and Company, United States
Mat Soukup, PhD Deputy Director, Division of Biometrics VII, OB, OTS CDER
FDA, United States
Mouna Akacha, PhD Group Head of Statistical Methodology
Novartis Pharma AG, Switzerland
Brenda Crowe, PhD Associate Vice President, Statistics
Eli Lilly and Company, United States
Jonathan Haddad, MPH HIV Disease Area Head, Clinical Statistics
GlaxoSmithKline, United States
Rima Izem, PhD Associate Director Statistical Methodology
Novartis, Switzerland
Shiowjen Lee, PhD Deputy Director, Division of Biostatistics, OBPV, CBER
FDA, United States
Cristiana Mayer, DrSc, PhD Head of Biostatistics
Johnson & Johnson Vision, United States
Lei Nie, PhD Director, Division of Biometrics IV, Office of Biostatistics, OTS, CDER
FDA, United States
Frank W. Rockhold, PhD, MSc Professor of Biostatistics
Duke Clinical Research Institute, Duke University Medical Center, United States
William Wang, PhD Executive Director
Merck & Co, Inc, United States
Aloka Chakravarty, PhD Director, Data Analytics
Office of Data, Analytics, & Research, Office of the Commissioner, FDA, United States